You are here

Pivotal Therapeutics Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
PVO
CSE Index: 
Currency: 

Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.

You are here

Pivotal Therapeutics Inc. (PVO)

SEDAR Information

Company Info

Address
81 Zenway Blvd Unit 10
Woodbridge, ON L4H 0S5
Canada
Phone
1-905-8569797
Fax
1-905-8562177
Email
EBortoluzzi@pivotaltherapeutics.us
Website
http://www.pivotaltherapeutics.us
Listing date
Thursday, May 19, 2011
Investor Relations
Pivotal Therapeutics Inc.
Auditor
MNP LLP.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
96,566,669
Reserved for Issuance: 
10,680,384

Bulletins

23/10/2017

2017-1012 - Delist - Pivotal Therapeutics Inc. (PVO)

October 23, 2017

The common shares of Pivotal Therapeutics Inc. will be delisted at the market close today, October 23, 2017. 

Pivotal Therapeutics is currently suspended. 

Date: Market close, October 23, 2017
Symbol: PVO

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_03_IIAC_Compliance_Operations_Symposium_Website

IIAC Compliance & Operations Symposium

Wednesday, April 3, 2019 (All day)
04_03_FFCON19_FEARLESS_Website_v2

FFCON19 FEARLESS

Wednesday, April 3, 2019 (All day) to Thursday, April 4, 2019 (All day)